MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image THIRD ROCK VENTURES LLC
THIRD ROCK VENTURES LLC

THIRD ROCK VENTURES LLC

HQ - Boston

Summary

Third Rock Ventures is a venture capital firm based in Boston, founded in 2007 which invests in biotechnology startups.

Deals Overview

Total Deals18
Valued Deals17
Total Value£ 3.51 B
Avg. Deal Size£ 206 M

Market Context

Investment Criteria

Target Equity Check-
Fund CurrencyUSD
Total funds raised$1-5bn

Investment Strategies

Early Stage

Geographic Preferences

United States

Industry Preferences

Pharmaceuticals and Biotechnology

Health Care Providers

Medical Equipment and Services

Pharmaceuticals

Sort

09 Jun 2016|United States|Pharmaceuticals
Afferent Pharmaceuticals
Merck & Co

Target: AFFERENT PHARMACEUTICALS INC

Bidder: MERCK & CO

1 Service Providers

1 Target

3 Dealmakers

3 Target

n/a

Value

26 May 2020|United States|Medical Services
INSITRO
Alexandria Venture Investments

Target: INSITRO

Bidder: ALEXANDRIA VENTURE INVESTMENTS

16 Service Providers

3 Target | 13 Bidder

38 Dealmakers

4 Target | 34 Bidder

£ 116 M

Value

03 Mar 2020|United States|Medical Equipment
Element Science
The Invus Group

Target: ELEMENT SCIENCE INC

Bidder: THE INVUS GROUP LLC

10 Service Providers

3 Target | 7 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 114 M

Value

27 Oct 2020|United States|Health Care Services
Thrive Earlier Detection Corp
Exact Sciences

Target: THRIVE EARLIER DETECTION CORP

Bidder: EXACT SCIENCES

17 Service Providers

3 Target | 4 Bidder | 10 Vendor

61 Dealmakers

27 Target | 11 Bidder | 23 Vendor

£ 1.65 B

Value

12 Mar 2020|United States|Pharmaceuticals
Nurix Therapeutics
Bain Capital Life Sciences

Target: NURIX THERAPEUTICS

Bidder: BAIN CAPITAL LIFE SCIENCES

7 Service Providers

2 Target | 5 Bidder

10 Dealmakers

4 Target | 6 Bidder

£ 95 M

Value

15 Mar 2021|United States|Medical Services
INSITRO
BLACKROCK

Target: INSITRO

Bidder: BLACKROCK

13 Service Providers

3 Target | 10 Bidder

27 Dealmakers

3 Target | 24 Bidder

£ 287 M

Value

10 May 2022|United States|Biotechnology
Moma Therapeutics
Rock Springs Capital

Target: MOMA THERAPEUTICS

Bidder: ROCK SPRINGS CAPITAL

15 Service Providers

2 Target | 13 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 121 M

Value

24 Mar 2022|United States|Biotechnology
Celsius Therapeutics
Third Rock Ventures

Target: CELSIUS THERAPEUTICS

Bidder: THIRD ROCK VENTURES LLC

2 Service Providers

1 Target | 1 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 68 M

Value

07 Mar 2023|United States|Biotechnology
Rapport Therapeutics
Third Rock Ventures

Target: RAPPORT THERAPEUTICS INC

Bidder: THIRD ROCK VENTURES LLC

4 Service Providers

2 Target | 2 Bidder

6 Dealmakers

4 Target | 2 Bidder

£ 83 M

Value

22 Mar 2023|United States|Biotechnology
Flare Therapeutics
Memorial Sloan Kettering Cancer Center

Target: FLARE THERAPEUTICS

Bidder: MEMORIAL SLOAN KETTERING CANCER CENTER

5 Service Providers

3 Target | 2 Bidder

6 Dealmakers

4 Target | 2 Bidder

£ 100 M

Value

01 Mar 2023|United States|Biotechnology
Cargo Therapeutics
Third Rock Ventures

Target: CARGO THERAPEUTICS

Bidder: THIRD ROCK VENTURES LLC

4 Service Providers

2 Target | 2 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 157 M

Value

11 Jul 2023|United States|Biotechnology
SEPTERNA
Ra Capital Management

Target: SEPTERNA

Bidder: RA CAPITAL MANAGEMENT

19 Service Providers

3 Target | 16 Bidder

19 Dealmakers

3 Target | 16 Bidder

£ 116 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite